New Tool Predicts Deadly Form of Rare Cancer
Genetic sequencing from biopsy can accurately predict which early-stage Cutaneous T Cell Lymphoma (CTCL) patients have aggressive form of this disease
Source: BWH News - Category: Hospital Management Source Type: news
More News: Cancer | Cancer & Oncology | Cutaneous T cell lymphoma | Genetics | Lymphoma | T-cell Lymphoma